Biogen
BIIB
BIIB
1,122 hedge funds and large institutions have $60B invested in Biogen in 2017 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 399 increasing their positions, 384 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.05% less ownership
Funds ownership: 89.15% → 89.1% (-0.05%)
26% less funds holding in top 10
Funds holding in top 10: 38 → 28 (-10)
32% less call options, than puts
Call options by funds: $989M | Put options by funds: $1.44B
Holders
1,122
Holding in Top 10
28
Calls
$989M
Puts
$1.44B
Top Buyers
| 1 | +$618M | |
| 2 | +$232M | |
| 3 | +$157M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$123M |
| 5 |
JP Morgan Chase
New York
|
+$106M |
Top Sellers
| 1 | -$684M | |
| 2 | -$230M | |
| 3 | -$160M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$155M |
| 5 |
O
OrbiMed
New York
|
-$127M |